Suppr超能文献

食品和膳食补充剂包装标签——来自美国食品药品监督管理局警告信及联邦法规汇编第21编的指导意见

Food and Dietary Supplement Package Labeling-Guidance from FDA's Warning Letters and Title 21 of the Code of Federal Regulations.

作者信息

Brody Tom

机构信息

Baker Hostetler LLP (law firm), 600 Anton Blvd., Costa Mesa, CA, 92626, U.S.A.

出版信息

Compr Rev Food Sci Food Saf. 2016 Jan;15(1):92-129. doi: 10.1111/1541-4337.12172. Epub 2015 Oct 12.

Abstract

Package labels for foods and dietary supplements must conform with Title 21 of the Code of Federal Regulations. This review provides guidance for the content and format of labels, including for the Nutrient Facts panel and Supplement Facts panel, and for drafting structure/function claims, health claims, and nutrient content claims. Also provided is guidance on how to refrain from drafting disease claims. Inappropriate disease claims on a food or dietary supplement compels FDA to review the product as a drug. Disease claims is the most common source of complaint in FDA's warning letters. This review makes use of all of FDA's warning letters that were published over a 14-y span (2002to 2015). This is the first comprehensive review on package labels to make use of FDA's warning letters as a source document.

摘要

食品和膳食补充剂的包装标签必须符合《联邦法规汇编》第21编的规定。本综述为标签的内容和格式提供指导,包括营养成分表和补充剂成分表,以及起草结构/功能声明、健康声明和营养成分声明。还提供了如何避免起草疾病声明的指导。食品或膳食补充剂上不恰当的疾病声明会迫使美国食品药品监督管理局(FDA)将该产品作为药品进行审查。疾病声明是FDA警告信中最常见的投诉来源。本综述利用了FDA在14年期间(2002年至2015年)发布的所有警告信。这是首次利用FDA警告信作为原始文件对包装标签进行的全面综述。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验